HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of chlorinated organics on intermediates in the heme pathway and on uroporphyrinogen decarboxylase.

Abstract
Experimental porphyria induced by PHAHs is characterized by a progressive reduction in the activity of UROD. After intoxication with TCDD, the most porphyrogenic compound known to date, the liver was the principal site of action, as regards both porphyrin accumulation (mostly uroporphyrin) and the degree of enzyme impairment; the kidney was the site of the second greatest accumulation; the brain and erythrocytes were unaffected. Additional modifications of the heme pathway involved induction of the activity of ALAS and, at least in HCB-induced porphyria after iron pretreatment, may have involved reduced activity of uroporphyrinogen III cosynthetase. These changes can alter the amount and the isomeric composition of uroporphyrinogens and uroporphyrins present in the liver in a way that is likely to help reduce formation of coproporphyrinogen III in porphyric animals. As in the human syndrome porphyria cutanea tarda, iron administration increased porphyrin accumulation and the degree of reduction of UROD activity in mice fed HCB. Mice fed HCB also presented an activation of the type O form of XO. This activation was independent of tissue injury derived from the lipid peroxidation that was concomitant with iron administration. The increase in activity of the type O form of XO may be a characteristic feature of the liver damage found in PHAH intoxication and, in intoxicated animals, could be a source in the liver of oxidant species involved in the mechanism of UROD inactivation--if this inactivation is in fact due to an oxidative reaction.
AuthorsL Cantoni, M Rizzardini, A Graziani, C Carugo, S Garattini
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 514 Pg. 128-40 ( 1987) ISSN: 0077-8923 [Print] United States
PMID3442377 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chlorobenzenes
  • Dioxins
  • Polychlorinated Dibenzodioxins
  • Heme
  • Hexachlorobenzene
  • Xanthine Oxidase
  • Carboxy-Lyases
  • Uroporphyrinogen Decarboxylase
Topics
  • Animals
  • Carboxy-Lyases (metabolism)
  • Chlorobenzenes (pharmacology)
  • Dioxins (pharmacology)
  • Heme
  • Hexachlorobenzene (pharmacology)
  • Liver (enzymology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Polychlorinated Dibenzodioxins (pharmacology)
  • Uroporphyrinogen Decarboxylase (metabolism)
  • Xanthine Oxidase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: